Search results

1. Effect of continuous renal replacement therapy with regional citrate anticoagulation on the concentrations of most commo…

Principal investigator: Ilona Nowak-Kózka

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: PRELUDIUM 8, Panel: NZ5

2. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

3. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

Principal investigator: dr hab. Radosław Zagożdżon

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

4. Efficiency biomarkers in photodynamic therapy against lung cancer

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: PRELUDIUM 2, Panel: NZ4

5. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Call: OPUS 28 (LAP), Panel: NZ5

6. Liposomal theranostic agent for magnetic resonance imaging and photodynamic therapy

Principal investigator: dr Paulina Krystyna Skupin-Mrugalska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 11, Panel: NZ7

7. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

8. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a…

Principal investigator: Natalia Anna Lehman

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 24, Panel: NZ4

9. Perinuclear AKAP6 signalosome as a new target for gene therapy in ischemic optic neuropathy

Principal investigator: dr hab. Tomasz Boczek

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: OPUS 22, Panel: NZ4

10. New approach for neuronal regeneration and survival following ischemic stroke - gene therapy based on MEF2A repression u…

Principal investigator: dr Malwina Anna Lisek

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: SONATA 16, Panel: NZ4

11. Glycoconjugated zinc phthalocyanine as a novel photodynamic therapy tool for the treatment of psoriasis

Principal investigator: prof. Piotr Paweł Ziółkowski

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: PRELUDIUM BIS 1, Panel: NZ4

12. The EBI2 receptor/oxysterol signalling in multiple sclerosis pathophysiology, therapy and diagnostics.

Principal investigator: dr Aleksandra Rutkowska

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 17, Panel: NZ4

13. Adeno-associated virus (AAV)-based gene therapy in the regeneration of optic nerve after ischemic stroke.

Principal investigator: dr hab. Tomasz Boczek

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: OPUS 17, Panel: NZ4

14. Development of the novel experimental gene therapy approach for glaucoma treatment - focusing on the role of RNA-binding…

Principal investigator: dr Adrian Smędowski

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

Call: SONATA 13, Panel: NZ4

15. Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases

Principal investigator: Natalia Iwona Kułach

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: PRELUDIUM 9, Panel: NZ4

16. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

Principal investigator: prof. Elżbieta Grzesiuk

Instytut Biochemii i Biofizyki PAN

Call: OPUS 2, Panel: NZ4

17. Modulations of DNA repair induced by anti cancer drugs by thiosugars

Principal investigator: dr hab. Tomasz Popławski

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 1, Panel: NZ4

18. Iron chelators- the novel approach to anticancer therapy

Principal investigator: Maciej Michał Serda

UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii

Call: PRELUDIUM 1, Panel: NZ4

19. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

Principal investigator: dr hab. Beata Kaleta

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

20. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

Principal investigator: dr Daniel Ryszard Ziental

Uniwersytet Przyrodniczy w Poznaniu

Call: SONATINA 9, Panel: NZ7

21. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

22. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

Principal investigator: dr Anna Dominika Walczak-Szeffer

Uniwersytet Medyczny w Łodzi

Call: SONATA 20, Panel: NZ5

23. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

Principal investigator: Dominik Jakub Dreszer

UNIWERSYTET ŚLĄSKI

Call: PRELUDIUM 23, Panel: NZ7

24. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o…

Principal investigator: dr Katarzyna Anna Malarz

Politechnika Śląska

Call: OPUS 27, Panel: NZ5

25. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

Principal investigator: Jaromir Bartosz Tomasik

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM 23, Panel: NZ5

26. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

27. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr…

Principal investigator: prof. Ewa Olędzka

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: OPUS 26, Panel: NZ7

28. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 25, Panel: NZ7

29. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

Principal investigator: Marika Anna Frańczak

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 22, Panel: NZ7

30. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

Principal investigator: Marta Krawczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 22, Panel: NZ7

31. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s…

Principal investigator: prof. Kinga Katarzyna Borowicz

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

Call: PRELUDIUM BIS 4, Panel: NZ7

32. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

Principal investigator: dr Urszula Helena Piotrowska

Warszawski Uniwersytet Medyczny

Call: SONATA 18, Panel: NZ7

33. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a…

Principal investigator: prof. Ewa Teresa Marcinkowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: PRELUDIUM BIS 4, Panel: NZ5

34. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Call: POLONEZ BIS 3, Panel: NZ5

35. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 23, Panel: NZ5

36. Phagocytic cells as boron carriers in boron neutron capture therapy

Principal investigator: Anna Maria Rudawska

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 21, Panel: NZ5

37. Modulation of HIV-1 epitranscriptome: A novel approach to improve "shock & kill" therapy.

Principal investigator: Haider Ali brak danych (PI has only a Name - in accordance with PESEL)

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: PRELUDIUM 21, Panel: NZ6

38. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i…

Principal investigator: dr Magdalena Olbryt

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 22, Panel: NZ7

39. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych PAN

Call: SONATA 17, Panel: NZ7

40. Structure-guided design of histone demethylase inhibitors for cancer therapy.

Principal investigator: dr Piotr Henryk Małecki

Instytut Chemii Bioorganicznej PAN

Call: SONATA 17, Panel: NZ7

41. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

Principal investigator: prof. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 22, Panel: NZ7

42. Monitoring and pharmacokinetics of midazolam by patients with COVID-19 receiving respirator and ECMO therapy.

Principal investigator: dr Marek Arnold Grochla

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Zabrzu

Call: PRELUDIUM 20, Panel: NZ6

43. Identification and use of natural human-tropic AAVs as vectors for gene therapy applications targeting human liver.

Principal investigator: prof. Leszek Lisowski

Wojskowy Instytut Medyczny

Call: OPUS 21, Panel: NZ5

44. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an…

Principal investigator: Szymon Tomczak

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 20, Panel: NZ5

45. Epigenetic Reprograming and All-trans-Retinoic Acid in Therapy of Myelodysplastic Syndromes

Principal investigator: prof. Artur Zygmunt Zelent

Instytut Genetyki i Hodowli Zwierząt PAN

Call: OPUS 21, Panel: NZ5

46. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

Principal investigator: Shaoshan Mai

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 20, Panel: NZ7

47. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Call: PRELUDIUM 20, Panel: NZ7

48. Identification of potential markers aiming early diagnostics of progression and tailoring metastasis-oriented therapies …

Principal investigator: dr Natalia Bednarz-Knoll

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Call: OPUS 20, Panel: NZ5

49. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 19, Panel: NZ7

50. New iron chelators from thiosemicarbazone group in photodynamic therapy

Principal investigator: Robert Bogumił Gawecki

UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

Call: PRELUDIUM 18, Panel: NZ7

Projects search